Search Results - "Matsuo, Koshi"

Refine Results
  1. 1
  2. 2

    Angioscopic Comparison of Resolute and Endeavor Zotarolimus-Eluting Stents by Nishimoto, Yuji, Matsuo, Koshi, Ueda, Yasunori, Sugihara, Ryuta, Hirata, Akio, Murakami, Ayaka, Kashiwase, Kazunori, Higuchi, Yoshiharu, Yasumura, Yoshio

    Published in Circulation Journal (2016)
    “…Background:Drug-eluting stents (DES) have reduced late loss and target lesion revascularization through the inhibition of neointimal hyperplasia, but instead…”
    Get full text
    Journal Article
  3. 3

    Atherosclerotic Change at One Year After Implantation of Endeavor Zotarolimus-Eluting Stent vs. Everolimus-Eluting Stent by Akazawa, Yasuhiro, Matsuo, Koshi, Ueda, Yasunori, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Nemoto, Takayoshi, Wada, Mitsuru, Murakami, Ayaka, Kashiwase, Kazunori, Kodama, Kazuhisa

    Published in Circulation Journal (2014)
    “…Background: Atherosclerosis progression is thought to be one of the mechanisms of late stent failure. Atherosclerosis progression is detected as yellow plaque…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Bacterial Contamination During Pacemaker Implantation Is Common and Does Not Always Result in Infection by Okada, Masato, Kashiwase, Kazunori, Hirata, Akio, Nemoto, Takayoshi, Matsuo, Koshi, Murakami, Ayaka, Ueda, Yasunori

    Published in Circulation Journal (2015)
    “…Background:Bacterial cultures of cardiovascular implantable electronic devices removed from patients without clinical infection are often positive, and the…”
    Get full text
    Journal Article
  7. 7

    Relationship Between Coronary Plaque Vulnerability and Serum n-3/n-6 Polyunsaturated Fatty Acid Ratio by Kashiyama, Toshikazu, Ueda, Yasunori, Nemoto, Takayoshi, Wada, Mitsuru, Masumura, Yuki, Matsuo, Koshi, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Kashiwase, Kazunori, Kodama, Kazuhisa

    Published in Circulation Journal (2011)
    “…Background: A low ratio of serum eicosapentaenoic acid to arachidonic acid (EPA/AA) has been associated with cardiovascular events. Higher-grade yellow color…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Risk of in-stent thrombus formation at one year after drug-eluting stent implantation by Higo, Tomoaki, Ueda, Yasunori, Matsuo, Koshi, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Nemoto, Takayoshi, Murakami, Ayaka, Kashiwase, Kazunori, Kodama, Kazuhisa

    Published in Thrombosis research (01-11-2011)
    “…Abstract Introduction Although very late stent thrombosis is an important problem with drug-eluting stents, risks for in-stent thrombus formation have not been…”
    Get full text
    Journal Article
  11. 11

    Frequency and Location of Yellow and Disrupted Coronary Plaques in Patients as Detected by Angioscopy by Masumura, Yuki, Ueda, Yasunori, Matsuo, Koshi, Akazawa, Yasuhiro, Nishio, Mayu, Hirata, Akio, Kashiwase, Kazunori, Nemoto, Takayoshi, Kashiyama, Toshikazu, Wada, Mitsuru, Muller, James E., Kodama, Kazuhisa

    Published in Circulation Journal (2011)
    “…Background: Clarification of frequency and distribution of yellow plaques and disrupted plaques will increase understanding of acute coronary syndrome (ACS)…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Chronic Kidney Disease and Coronary Artery Vulnerable Plaques by Wada, Mitsuru, Ueda, Yasunori, Higo, Tomoaki, Matsuo, Koshi, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Nemoto, Takayoshi, Kashiyama, Toshikazu, Murakami, Ayaka, Kashiwase, Kazunori, Kodama, Kazuhisa

    “…Chronic kidney disease (CKD) is a risk factor of cardiovascular disease. The number of yellow plaques is a predictor of future cardiovascular events. We…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20